Skip to main content
Download PDF

Development and validation of a nomogram to predict perioperative blood transfusion in patients undergoing total knee arthroplasty

BMC Musculoskeletal Disorders volume 21, Article number: 315 (2020) Cite this article

Abstract

Background

The need for a transfusion is one of the adverse events following total knee arthroplasty (TKA), and accurately predicting this need remains challenging for arthroplasty surgeons. The purpose of the present research is to study the preoperative predictors of transfusion risk in patients following TKA and develop a nomogram.

Methods

The nomogram was developed based on a training set of 5402 patients who underwent TKA at the Affiliated Hospital of Qingdao University between September 2013 and November 2018. The independent predictors of transfusion were identified by univariate, LASSO, and binary logistic regression analyses. Then, a nomogram was established based on these independent predictors. The area under the curve (AUC), calibration curve, and decision curve analysis (DCA) were selected to evaluate the nomogram. The results were validated using an independent set of 1116 patients who underwent TKA between December 2018 and September 2019. In addition, we also carried out subgroup analyses in the training and testing sets based on the independent predictors.

Results

Five independent predictors were identified by multivariate analysis and were used to establish the nomogram. The AUCs of the nomogram were 0.884 (95% CI: 0.865–0.903) and 0.839 (95% CI, 0.773–0.905) in the training and testing sets, respectively. In both the training and testing sets, the calibration curve indicated that the prediction by the nomogram was highly consistent with the actual observation, and the DCA indicated that the nomogram had a favorable level of clinical usefulness. In addition, the AUC of the nomogram was significantly higher than the AUC of any independent predictor for predicting transfusion risk following TKA, and the subgroup analysis showed good performance in 20 subgroups.

Conclusion

Lower preoperative Hb levels, simultaneous bilateral TKA, lower BMI, older age, and coronary heart disease were identified as independent predictors of postoperative transfusion in patients following TKA. A nomogram incorporating the above five predictors could accurately predict the transfusion risk.

Peer Review reports

Background

Total knee arthroplasty (TKA) is a cost-effective procedure for end-stage knee disease, with outcomes that have been confirmed by previous studies. However, due to perioperative blood loss, some patients require allogenic blood transfusion after TKA. The reported incidence of transfusion varies from 3.5–29.1% in TKA patients [1,2,3]. Although blood transfusion can increase the hemoglobin level and improve postoperative recovery, it is an important risk factor for many catastrophic complications, such as deep venous thrombosis [4], surgical site infection [5], and periprosthetic joint infection [6]. In addition, blood transfusion can lead to an increase in the length of stay and costs, which creates a larger economic burden for society [7].

Several strategies have been used to reduce the risk for transfusion in TKA patients, such as the use of a tourniquet and tranexamic acid [8, 9]. Unfortunately, the side effects of these strategies continue to worry orthopedists, and some patients still need blood transfusions. Therefore, it is necessary for us to recognize high-risk patients early for specific interventions that can reduce the transfusion risk following TKA.

Currently, nomograms are widely used as prognostic devices in medicine. In a nomogram, multiple risk factors can be combined to predict the probability of outcomes and visualize the results. However, no previous study has reported the predictive value of a nomogram for postoperative transfusion in patients following TKA. Therefore, our study aimed to investigate the incidence and preoperative risk factors for transfusion in patients following TKA and develop a preoperative nomogram for predicting transfusion risk following TKA.

Methods

We retrospectively reviewed 6062 consecutive patients who underwent TKA from September 2013 to November 2018 at the Affiliated Hospital of Qingdao University (Shandong, China). The inclusion criteria were as follows: primary bilateral or unilateral TKA; no history of knee joint infection; and no history of transfusion within 1 month before TKA. The exclusion criteria were as follows: periarticular tumor; revision TKA; TKA combined with other operations simultaneously; staged bilateral TKA interval within 1 month; and incomplete data. Moreover, from December 2018 to September 2019, we prospectively included patients who underwent TKA in our hospital with the same inclusion and exclusion criteria to create the testing set.

The variables collected in our research are shown in Table 1. All data were independently collected from our hospital’s medical recording system by two arthroplasty surgeons, and any controversial data were agreed upon by the two doctors who extracted the data and a third independent arthroplasty surgeon. In addition, in our research, the transfusion group was defined as patients who received allogenic blood transfusion within 14 days after TKA. Moreover, it should be pointed out that the indication for transfusion in our institution is patients with a Hb < 70 g/L or patients with Hb < 80 g/L but with symptoms of anemia.

Table 1 Comparison of preoperative variables between the two groups
Full size table

All patients included in our study underwent TKA that was performed by senior arthroplasty surgeons in our hospital following an identical protocol. A midline incision in the knee joint and medial parapatellar approach were used. Posterior Cruciate-Stabilizing prosthesis (NexGen LPS-Flex, Zimmer, Warsaw, IN) or Medial Pivot prosthesis (Advance Medial - Pivot Knee System, Wright Medical Group, Arlington, TN) were selected and fixed with cement. One intra-articular drainage line was used in each joint and removed within 48 h after TKA. When the joint capsule was closed, the patients who received TXA received 1 g TXA through the drainage line. All patients underwent rehabilitation exercises following a unified rehabilitation program, and rehabilitation work was guided by a professional therapist.

Statistical analysis

All statistical analyses were performed with SPSS (version 24, IBM, USA) and R software (version 3.6.1, R Foundation for Statistical Computing, Austria). The normality of continuous variables was determined by the Kolmogorov-Smirnov test or the Shapiro-Wilk test in SPSS. The continuous data are presented as the mean ± SD or median (interquartile range), while the categorical data are presented as a number or percentage. In univariate analysis, Student’s t-test or Mann-Whitney U test was used for continuous variables, and the chi-square test or Fisher’s exact test was used for categorical variables. Predictors with a P value< 0.1 were included in the LASSO regression to avoid overfitting. Then, logistic regression analysis was performed to determine the independent predictors for transfusion in patients following TKA.

A nomogram was established based on the independent predictors in R software. The area under the curve (AUC) based on the receiver operating characteristic (ROC) curve was used to evaluate the discrimination of the nomogram. Furthermore, the calibration curve was used to evaluate the calibration of the nomogram, and decision curve analysis (DCA) was used to estimate the clinical usefulness of the nomogram in the training and testing sets. In addition, the ROC curves of each independent predictor were established, and comparisons of the AUCs between the nomogram and independent risk factors was performed. Finally, to confirm the predictive ability of the nomogram in subgroups, the patients were divided into subgroups according to the independent predictors, and the median of value of each continuous variable was used as the cutoff. The ROC curves of the nomogram and each independent predictor in each subgroup were generated, and the AUCs were identified. A P value< 0.05 (two-sided) was considered significant.

Results

From September 2013 to November 2018, 6062 consecutive patients underwent TKA in the Affiliated Hospital of Qingdao University, and 5402 patients were included in the training cohort (Fig. 1). There were 1249 males and 4153 females. The mean age of the patients was 65.92 ± 7.38 years old (range: 33–90 years old), and the average body mass index (BMI) was 27.36 ± 3.92 kg/m2 (range: 13.11–62.50 kg/m2). Among these patients, 801 underwent simultaneous bilateral TKA, while 4601 underwent unilateral TKA.

Fig. 1
figure 1

A nomogram based on independent risk factors for predicting transfusion risk following TKA. TKA: Total knee arthroplasty; CHD: Coronary heart disease; Hb: Hemoglobin; BMI: Body mass index

Full size image

Independent risk factors for transfusion in the training set

In the training set, 391 patients received transfusions within 14 days after TKA, and the incidence of postoperative transfusion was 7.2%. Seventeen variables with a P value < 0.1 in the univariate analysis were included in the LASSO regression analysis, and fourteen variables were determined as significant predictors (Supplementary Fig. 1). Then, binary logistic regression analysis demonstrated that simultaneous bilateral TKA, coronary heart disease, Hb level, age, and BMI were independent predictors of postoperative transfusion following TKA (Table 2). The preoperative Hb value reported had the highest score, which suggested that this parameter had the greatest impact on the model.

Table 2 Multivariate logistic analysis of transfusion in patients following TKA
Full size table

Development and validation of a nomogram for predicting transfusion risk

Five independent predictors were used to establish a nomogram (Fig. 1), and the points of each variable are shown in supplementary Table 1. The AUC of our nomogram was 0.884 (95% CI, 0.865–0.903) in the training set (Fig. 2a), showing good accuracy in predicting the risk of transfusion in patients following TKA. The favorable calibration curve indicated that the prediction by the nomogram was highly consistent with the actual observation (Fig. 2b). Moreover, DCA showed that if the threshold probability of a patient and a doctor was higher than > 2 and < 94%, using this nomogram to predict transfusion risk adds more benefit than the scheme (Fig. 2c).

Fig. 2
figure 2

The receiver operating characteristic curve (a), calibration curve (b), and decision curve analysis (c) of training set. The receiver operating characteristic curve (d), calibration curve (e), and decision curve analysis (f) of testing set

Full size image

A total of 1116 patients were included in the testing set, and 52 patients received transfusions within 14 days after TKA. In the testing set, the AUC of the nomogram was 0.839 (95% CI: 0.773–0.905) (Fig. 2d), and the calibration curve showed good agreement between the prediction and observation regarding the probability of transfusion (Fig. 2e). Furthermore, the DCA demonstrated that if the threshold probability of a patient and a doctor was > 1 and < 62%, using the nomogram to predict postoperative transfusion has a net benefit (Fig. 2f).

Comparison of the AUCs of the nomogram and a single factor for predicting transfusion risk

The ROC curves of the nomogram, Hb, age, BMI, TKA procedure and CHD in the training set were generated (Fig. 3a). The results demonstrated that the AUC of the nomogram was significantly higher than the AUCs of each single independent predictor of transfusion risk in patients following TKA (all P values< 0.001) (Fig. 3a). Similar to the training set, in the testing set, the AUC of the nomogram was also significantly higher than the AUCs of each independent predictor in the testing set (all P values< 0.001) (Fig. 3b).

Fig. 3
figure 3

The receiver operating characteristic curves with corresponding area under the curves of nomogram and independent predictors in training set (a) and testing set (b). CHD: Coronary heart disease; Hb: Hemoglobin; BMI: Body mass index

Full size image

Subgroup analysis of the nomogram

To determine the predictive performance of the nomogram in subgroups, the patients were divided into subgroups based on categorical variables or the median of independent predictors. We found that the nomogram can serve as a promising predictive tool for transfusion risk in patients following TKA in different subgroups, with AUCs ranging from 0.691–0.898 and 0.745–0.938 in the training set (Supplementary Fig. 2A- 2J) and testing set (Supplementary Fig. 2 K-2 T), respectively. More importantly, in most of the subgroups (8/10 in the training set and 5/10 in the testing set), the AUCs of the nomogram were significantly higher than those of each independent predictor.

Discussion

In our study, a nomogram based on five preoperative predictors was established and confirmed as a tool that can accurately predict the postoperative transfusion risk of TKA patients. By using this nomogram, improved individualized patient counseling and decision-making regarding perioperative blood management for TKA patients can be achieved.

Although some predictive models have been established in previous studies, we think our study improves upon the previous work. In the predictive tools established by Noticewala et al. and Ahmed et al. [10, 11], only patients who underwent unilateral TKA were included. Conversely, in our study, patients who underwent unilateral and those who underwent bilateral TKA were included. More importantly, by subgroup analysis, we confirmed that our nomogram can perform well in both the unilateral TKA cohort and the bilateral TKA cohort. In addition, the advantages of our study compared with the predictive model generated by Jo et al. [12] are as follows. First, there was an improvement in the definition of the transfusion group. In the previous study, the definition of patients in the transfusion group was defined as patients with Hb < 70 g/L following TKA. Differently, in our study, patients who needed transfusions were defined as patients who actually received allogenic blood transfusion within 14 days after TKA. Although a Hb level of 70 g/L is the transfusion threshold that is adopted by many hospitals, some patients do not need to receive blood transfusions when their Hb < 70 g/L [13]. In addition, a recent study indicated that transfusion thresholds can be Hb values greater than 70 g/L during actual clinical practice [14]. Therefore, defining transfusion as patients with Hb < 70 g/L may cause a discrepancy with the criteria in clinical practice.

In our research, five independent variables were confirmed as predictors of transfusion. Their relationship to transfusion has been extensively reported in previous studies. Preoperative Hb level is one of the most important predictors of postoperative transfusion in patients following TKA, for both unilateral or simultaneous bilateral TKA [1, 2]. In addition, a recent study showed that preoperative Hb levels can still be used as an important predictor for postoperative transfusion in patients with TKA using antifibrinolytic drugs [15]. Interestingly, the use of tranexamic acid was not determined to be an independent predictor of blood transfusion in our study. However, a recent study reported that the use of tranexamic acid can effectively reduce the transfusion risk in patients undergoing unilateral TKA [9]. Unfortunately, the management of tranexamic acid can result in different outcomes, and there is no consensus on how to use tranexamic acid for TKA [16, 17]. Therefore, the dosage, administration route and administration time need to be further studied in future research.

Compared with those undergoing unilateral TKA, patients undergoing simultaneous bilateral TKA have a higher risk of transfusion. Similar results have been described in previous studies, and longer operation times and more perioperative blood loss may be the reason behind this result [18,19,20]. Our study suggested that patients with lower BMIs had a higher risk of transfusion. Patients with higher BMIs have a higher blood volume. Therefore, the percentage of perioperative blood loss in these patients is relatively low compared with that of patients with lower BMIs. In addition, we found that age was an independent risk factor for postoperative blood transfusion in patients with TKA, although it was not a significant factor in univariate analysis. Previous studies for elective arthroplasty have reported similar results [12, 15, 21,22,23].

Interestingly, with a strict statistical analysis, the results showed that coronary heart disease is one of the risk factors for postoperative blood transfusion in patients following TKA, and this finding has rarely been reported in previous studies. Recently, XU et al. identified that coronary heart disease is one of the risk factors for transfusion in patients following total joint arthroplasty [24]. In addition, Malcherczyk et al. [25] reported that coronary heart disease is a risk factor for postoperative blood transfusion in patients with shoulder arthroplasty. However, the potential mechanism between coronary heart disease and transfusion remains unclear. A possible explanation for this phenomenon is that patients with multiple diseases are more likely to use drugs that affect blood coagulation and have a higher risk of anemia [26]. In addition, the role of anti-inflammatory or antiplatelet drugs in blood management cannot be ignored. Recent meta-analyses showed that early hip fracture surgery was significantly related to a higher transfusion rate in patients with antiplatelet treatment than patients without antiplatelet treatment [27]. Therefore, antiplatelet drugs may play a role in influencing blood administration for TKA patients, and we will further study this potential mechanism in a later study. In addition, recent meta-analyses reported that patient-specific instrumentation decreased blood loss, but did not decrease transfusion rate [28]. Therefore, the complex relationship among coagulation, blood loss, and blood transfusion also need to be further studied.

Based on a large cohort, a preoperative nomogram was established and successfully validated in an independent cohort. All variables incorporated in the nomogram were easy to determine. By calculating the points of each of the five preoperative variables, arthroplasty surgeons can easily estimate the risk of postoperative transfusion before surgery. According to the evaluation results, the preoperative management strategy can be specified to reduce the risk of transfusion for high-risk patients. Similarly, for low-risk patients, some preventive measures could be reduced to decrease the economic burden and the risk of side effects [29].

There are also some limitations in our study. First, this is a retrospective study, so there may be inherent selection biases. However, we included as many preoperative factors as possible based on a large sample size to minimize biases. Second, although this nomogram has been verified by an independent cohort, we must realize that different blood transfusion policies in different hospitals, states and countries may limit the application of this nomogram to a few hospitals. Finally, although this nomogram showed excellent predictive power for postoperative blood transfusion, we must recognize the effect of surgical procedures on postoperative transfusion. Operation time, intraoperative blood loss, and intraoperative hemostasis are important factors influencing the transfusion rate in patients with TKA. Further prospective multicenter studies should be performed to further validate our nomogram.

Conclusion

This study identified that lower preoperative Hb levels, simultaneous bilateral TKA, lower BMI, older age, and coronary heart disease are independent risk factors for postoperative transfusion in patients following TKA. A nomogram incorporating the above five predictors could accurately predict the transfusion risk.

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

TKA:

Total Knee Arthroplasty

AUC:

Area Under the Curve

DCA:

Decision Curve Analysis

BMI:

Body Mass Index

CCI:

Charlson Comorbidity Index

TXA:

Tranexamic Acid

RET:

Reticulocyte

MCV:

Mean Corpuscular Volume

MCH:

Mean Corpuscular Hemoglobin

MCHC:

Mean Corpuscular Hemoglobin Concentration

Hb:

Hemoglobin

RDW:

Red Blood Cell Distribution Width

PLT:

Platelet

PDW:

Platelet Distribution Width

References

  1. Song K, Pan P, Yao Y, Jiang T, Jiang Q. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. J Orthop Surg Res. 2019;14(1):273.

    Article  Google Scholar 

  2. Cao G, Huang Z, Huang Q, Zhang S, Xu B, Pei F. Incidence and risk factors for blood transfusion in simultaneous bilateral Total joint Arthroplasty: a multicenter retrospective study. J Arthroplast. 2018;33(7):2087–91.

    Article  Google Scholar 

  3. Menendez ME, Lu N, Huybrechts KF, Ring D, Barnes CL, Ladha K, et al. Variation in Use of Blood Transfusion in Primary Total Hip and Knee Arthroplasties. J Arthroplasty. 2016;31(12):2757–2763.e2752.

    Article  Google Scholar 

  4. Jiang T, Song K, Yao Y, Pan P, Jiang Q. Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty. J Orthop Surg Res. 2019;14(1):235.

    Article  Google Scholar 

  5. Everhart JS, Sojka JH, Mayerson JL, Glassman AH, Scharschmidt TJ. Perioperative allogeneic red blood-cell transfusion associated with surgical site infection after Total hip and knee Arthroplasty. J Bone Joint Surg Am. 2018;100(4):288–94.

    Article  Google Scholar 

  6. Zhu Y, Zhang F, Chen W, Liu S, Zhang Q, Zhang Y. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect. 2015;89(2):82–9.

    Article  CAS  Google Scholar 

  7. Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, et al. Are allogeneic transfusions decreasing in Total knee Arthroplasty patients? National Inpatient Sample 2009-2013. J Arthroplast. 2018;33(6):1705–12.

    Article  Google Scholar 

  8. Kim TK, Bamne AB, Sim JA, Park JH, Na YG. Is lower tourniquet pressure during total knee arthroplasty effective? A prospective randomized controlled trial. BMC Musculoskelet Disord. 2019;20(1):275.

    Article  Google Scholar 

  9. Tille E, Mysliwietz J, Beyer F, Postler A, Lützner J. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty. BMC Musculoskelet Disord. 2019;20(1):341.

    Article  Google Scholar 

  10. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplast. 2012;27(6):961–7.

    Article  Google Scholar 

  11. Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P. Estimating the transfusion risk following total knee arthroplasty. Orthopedics. 2012;35(10):e1465–71.

    Article  Google Scholar 

  12. Jo C, Ko S, Shin WC, Han H-S, Lee MC, Ko T. Transfusion after total knee arthroplasty can be predicted using the machine learning algorithm. Knee Surg Sports Traumatol Arthrosc. 2019:1–8.

  13. Deleu F, Deneux-Tharaux C, Chiesa-Dubruille C, Seco A, Bonnet MP. A population-based analysis of French transfusion practices for women experiencing severe postpartum hemorrhage. Int J Obstet Anesth. 2019.

  14. Rahimi-Levene N, Ziv-Baran T, Peer V, Golik A, Kornberg A, Zeidenstein R, et al. Hemoglobin transfusion trigger in an internal medicine department–a" real world" six year experience. PLoS One. 2018;13(3):e0193873.

    Article  Google Scholar 

  15. Ryan SP, Klement MR, Green CL, Blizzard DJ, Wellman SS, Seyler TM. Preoperative hemoglobin predicts postoperative transfusion despite Antifibrinolytics during Total knee Arthroplasty. Orthopedics. 2019;42(2):103–9.

    Article  Google Scholar 

  16. Legnani C, Oriani G, Parente F, Ventura A. Reducing transfusion requirements following total knee arthroplasty: effectiveness of a double infusion of tranexamic acid. Eur Rev Med Pharmacol Sci. 2019;23(5):2253–6.

    CAS  PubMed  Google Scholar 

  17. Tsukada S, Kurosaka K, Nishino M, Maeda T, Yonekawa Y, Hirasawa N. Intra-articular tranexamic acid as an adjunct to intravenous tranexamic acid for simultaneous bilateral total knee arthroplasty: a randomized double-blind, placebo-controlled trial. BMC Musculoskelet Disord. 2019;20(1):464.

    Article  Google Scholar 

  18. Mufarrih SH, Qureshi NQ, Ali A, Malik AT, Naim H, Noordin S. Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the south Asian population. BMC Musculoskelet Disord. 2017;18(1):359.

    Article  Google Scholar 

  19. Ross D, Erkocak O, Rasouli MR, Parvizi J. Operative time directly correlates with blood loss and need for blood transfusion in Total joint Arthroplasty. Arch Bone Jt Surg. 2019;7(3):229–34.

    PubMed  PubMed Central  Google Scholar 

  20. Nichols CI, Vose JG. Comparative Risk of Transfusion and Incremental Total Hospitalization Cost for Primary Unilateral, Bilateral, and Revision Total Knee Arthroplasty Procedures. J Arthroplasty. 2016;31(3):583–589.e581.

    Article  Google Scholar 

  21. Kaiser C, Tillmann FP, Lochter J, Landgraeber S, Jager M. The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty. Int Urol Nephrol. 2019;51(1):147–53.

    Article  CAS  Google Scholar 

  22. Slover J, Lavery JA, Schwarzkopf R, Iorio R, Bosco J, Gold HT. Incidence and Risk Factors for Blood Transfusion in Total Joint Arthroplasty: Analysis of a Statewide Database. J Arthroplasty. 2017;32(9):2684–2687.e2681.

    Article  Google Scholar 

  23. To J, Sinha R, Kim SW, Robinson K, Kearney B, Howie D, To LB. Predicting perioperative transfusion in elective hip and knee Arthroplasty: a validated predictive model. Anesthesiology. 2017;127(2):317–25.

    Article  Google Scholar 

  24. Xu H, Xie J, Lei Y, Huang Q, Huang Z, Pei F. Closed suction drainage following routine primary total joint arthroplasty is associated with a higher transfusion rate and longer postoperative length of stay: a retrospective cohort study. J Orthop Surg Res. 2019;14(1):163.

    Article  Google Scholar 

  25. Malcherczyk D, Hack J, Klasan A, Abdelmoula A, Heyse TJ, Greene B, et al. Orthopaedics E-ZBJI: differences in total blood loss and transfusion rate between different indications for shoulder arthroplasty. Int Orthop. 2019;43(3):653–8.

    Article  Google Scholar 

  26. Madsen CM, Jørgensen HL, Norgaard A, Riis T, Jantzen C, Pedersen OB, et al. Preoperative factors associated with red blood cell transfusion in hip fracture patients. Arch Orthop Trauma Surg. 2014;134(3):375–82.

    Article  Google Scholar 

  27. Yang Z, Ni J, Long Z, Kuang L, Gao Y, Tao S. Is hip fracture surgery safe for patients on antiplatelet drugs and is it necessary to delay surgery? A systematic review and meta-analysis. J Orthop Surg Res. 2020;15(1):105.

    Article  Google Scholar 

  28. Kizaki K, Shanmugaraj A, Yamashita F, Simunovic N, Duong A, Khanna V, et al. Total knee arthroplasty using patient-specific instrumentation for osteoarthritis of the knee: a meta-analysis. BMC Musculoskelet Disord. 2019;20(1):561.

    Article  CAS  Google Scholar 

  29. Maiorano E, Bodini BD, Cavaiani F, Pelosi C, Sansone V. Length of stay and short-term functional outcomes after total knee arthroplasty: can we predict them? Knee. 2017;24(1):116–20.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to thank the entire staff of the Department of Orthopedics, Affiliated Hospital of Qingdao University for their contribution to our research.

Funding

We received no external funding for this study.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China

    Chuan Hu, Yuan-he Wang, Rui Shen, Kang Sun, Xu Yang, Shao-qi Tian & Teng-bo Yu

  2. Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China

    Chuan Liu

  3. Wenzhou Medical University, Wenzhou, 325000, China

    Lin Ye & Jian-jun Ye

Authors
  1. Chuan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-he Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rui Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lin Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian-jun Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shao-qi Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Teng-bo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

C H, SQ T, TB Y and K S conceived and designed the study. C H, YH W and C L performed the literature search. R S, JJ Y and C L generated the figures and Tables. L Y, X Y and C H analyzed the data. C H and SQ T wrote the manuscript, and TB Y critically reviewed the manuscript. C H, TB Y, SQ T and K S supervised the research. The author (s) read and approved the final manuscript.

Corresponding authors

Correspondence to Shao-qi Tian or Teng-bo Yu.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of the Affiliated Hospital of Qingdao University. Written informed consent was obtained from all patients. No children (under 16 years old) were included in this study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1 Supplementary Fig. 1:

The results of LASSO regression analysis.

Additional file 2 Supplementary Fig. 2:

The ROC curve showed the subgroup analysis of nomogram based on the categorical or the median of independent predictors. Training set(A-J); testing set(K-T). ROC: receiver operating characteristic; AUC: Area under the curve; CHD: Coronary heart disease; Hb: Hemoglobin; BMI: Body mass index.

Additional file 3 Table 1

. Point of variables in the nomogram.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, C., Wang, Yh., Shen, R. et al. Development and validation of a nomogram to predict perioperative blood transfusion in patients undergoing total knee arthroplasty. BMC Musculoskelet Disord 21, 315 (2020). https://doi.org/10.1186/s12891-020-03328-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-020-03328-9

Keywords

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us